Atypical Dermatitis Herpetiform and Scalp Psoriasis in Ulcerative Colitis Patient Treated With Adalimumab

Adalimumab is a blocker of tumor necrosis factor (TNF)-alpha with established efficacy in the treatment of ulcerative colitis. However, literature indicated that adalimumab can, occasionally, induce paradoxical psoriasis reactions and, very rarely, dermatitis herpetiformis. We present a unique case...

Descripción completa

Detalles Bibliográficos
Autores principales: Alshehri, Hamza, Alshehri, Afnan, bin Abbas, Abrar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2023
Materias:
Dermatology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9947429/
https://www.ncbi.nlm.nih.gov/pubmed/36846641
http://dx.doi.org/10.7759/cureus.35317

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9947429/
https://www.ncbi.nlm.nih.gov/pubmed/36846641
http://dx.doi.org/10.7759/cureus.35317

Ejemplares similares